Hugging Face released Carbon-X, an open AI model that lets researchers put DNA sequences into a chat and ask questions in ordinary language. Its model card describes predictions about whether mutations are benign or pathogenic and which regions control gene activity.
Lewis Tunstall, a senior research scientist at Hugging Face, told Business Insider that a researcher could ask whether a mutation might increase disease risk and get a prediction and explanation. WIRED quotes Tunstall as saying the tool is meant to help researchers design drugs and genetic therapies and could potentially help patients interpret their genomes.
The model and its limits
According to Hugging Face’s model card, Carbon-X has 14.8 billion parameters and starts from Qwen3-14B. Its developers trained it on DNA and natural-language text, using a tokenizer that reads DNA in six-base groups. They report 302 billion tokens of mid-training, followed by supervised fine-tuning and reinforcement learning.
Hugging Face says the model’s weights fit on a single 80 GB GPU in bfloat16 and documents ways to run it with vLLM and Transformers. That does not extend to a full human genome: WIRED describes inputs of roughly 50,000 base pairs and says users cannot upload full human genomes. The model card says inputs substantially longer than those used in training have not been evaluated.
Predictions are not a diagnosis
Hugging Face reports an average score of 66.7% across five DNA benchmarks with thinking disabled, compared with 67.5% for GPT-6.1 Sol under its comparison settings. The Carbon-X team built two of those benchmarks, FrontierVEP and NextBase. The model card also warns that Carbon-X can miscount bases, confuse coordinates or invent a sequence’s identity or function when context is missing.
More fundamentally, the model card says Carbon-X has not been clinically validated and should not be used to make medical decisions. WIRED reports that its developers have not validated it in wet-lab experiments, so they cannot say how accurate its predictions are.
Comments